RP-HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-19. Anything still debated is marked as such rather than presented as settled.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。
在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
28 September The 15-year-old girl killed in Croydon, South London the previous day is named locally as Elianne Andam. Police are given an extra 24 hours to question the 17-year-old suspect. The landmark Sycamore Gap Tree, beside Hadrian's Wall in Northumberland, is illegally felled. A 16-year-old boy is subsequently arrested on suspicion of criminal damage. 29 September A school bus carrying 58 people overturns between junction 4 and 5 of the M53 motorway, killing a 15-year-old girl and the driver. A major incident is declared by North West Ambulance Service and Liverpool's Alder Hey Children's Hospital. Dozens of others are treated for injuries, and several are hospitalised. A 17-year-old boy appears in court charged with the murder of Elianne Andam, and is remanded in youth detention to appear before the Old Bailey on 3 October. A second person – a man in his 60s – is arrested in correction with the cutting-down of the world-famous Sycamore Gap Tree. The 16-year-old boy arrested over the incident the previous day is released on bail. In an interview with The Sun, Prime Minister Rishi Sunak reinforces his pro-motorist stance, saying he wants to stop "hare-brained" road calming and safety schemes – including 20 mph zones and low-traffic neighbourhoods – putting an end to what he refers to as a "war on motorists".
== Predicting from DNA/RNA sequences == In biology, proteins are produced by translation of messenger RNA (mRNA) with the protein sequence deriving from the sequence of codons in the mRNA. The mRNA is itself formed by the transcription of genes and may be further modified. These processes are sufficiently understood to use computer algorithms to automate predictions of protein sequences from DNA sequences, such as from whole-genome DNA-sequencing projects, and have led to the generation of large databases of protein sequences such as UniProt. Predicted protein sequences are an important resource for protein identification by mass spectrometry. Historically, short protein sequences (10 to 15 residues) determined by Edman degradation were back-translated into DNA sequences that could be used as probes or primers to isolate molecular clones of the corresponding gene or complementary DNA. The sequence of the cloned DNA was then determined and used to deduce the full amino-acid sequence of the protein.
=== Non-inhibitory roles === Non-inhibitory extracellular serpins also perform a wide array of important roles. Thyroxine-binding globulin and transcortin transport the hormones thyroxine and cortisol, respectively. The non-inhibitory serpin ovalbumin is the most abundant protein in egg white. Its exact function is unknown, but it is thought to be a storage protein for the developing foetus. Heat shock serpin 47 is a chaperone, essential for proper folding of collagen. It acts by stabilising collagen's triple helix whilst it is being processed in the endoplasmic reticulum. Some serpins are both protease inhibitors and perform additional roles. For example, the nuclear cysteine protease inhibitor MENT, in birds also acts as a chromatin remodelling molecule in a bird's red blood cells.
== Awards == Bowman was awarded the Pittcon Heritage Award in 2015, recognizing him for "providing the dedication, leadership and vision to commercialize ion chromatography and foster its evolution to a technology of critical importance for academic and a broad range of industries."
A liquid coolant—typically either liquid nitrogen (−196 °C, 77ºK, −320 °F) or 99% ethanol chilled with dry ice (−72 °C, 201ºK, −98 °F)—is used to bring the brand head down to its working temperature in an appropriately insulating container. Other coolants historically used with dry ice have included acetone, isopropanol, methanol, gasoline, kerosene and jet fuel. There is some anecdotal evidence that the lower viscosity of chilled acetone makes for whiter brands, presumably through better heat conduction. Experimental work has also been carried out using the direct application of coolants to an animal's skin. Freons 12, 21, 22 and 31 have all been evaluated as direct coolants, either as a spray or a slushy mixture of freon ice and liquid. Freons were chosen because they can be bought in pressurized cans that produce cryogenic temperatures when vented. This convenience was desirable aboard a ship or amid pinniped colonies to tag sea mammals for scientific study. Direct freezing with CFCs proved cumbersome and difficult to control, requiring custom masks to form an intentional pattern. The method has largely been abandoned since the Vienna Convention. Cryogenic alcohol baths readily absorb water from atmospheric humidity, producing slush. This slush is a poor conductor of heat and will ruin brands. If alcohol baths are to be used for a series of brandings the alcohol must be replaced every two hours from a fresh 99% supply. This hygroscopic phenomenon was the original impetus to seek non-water soluble coolants such as kerosene and jet fuel during the technique's development.
Sources: en.wikipedia.org
Newsom oversaw a sluggish initial rollout of vaccines; California had one of the lowest vaccination rates in the country by January 2021, and had only used about 30% of the vaccines it had at its disposal, a far lower rate than other states, by January 20. Newsom had an approval rating of 64% in September 2020, but a February 2021 UC Berkeley Institute of Governmental Studies poll found that his approval rate was down to 46%, with 48% disapproval, the highest of his tenure. The Los Angeles Times attributed this decline to public opinion of his management of the pandemic. The vaccination rate began increasing in January, with over half the population fully vaccinated as of September 2021, the percentage ranking #16 out of the 50 states. While the Newsom administration enacted some of the country's most stringent pandemic restrictions in 2020, by May 2021 California had the 29th-highest COVID-19 death rate among the 50 states. Monica Gandhi, a professor of medicine at UCSF, said that California's restrictive approach "did not lead to better health outcomes", and criticized California's delay in implementing new CDC recommendations absolving the fully vaccinated from most indoor mask requirements, saying the decision lacked a scientific rationale and could cause "collateral damage".
Although Mr Galloway, Mr Halford and Mr Al-Mukhtar have confirmed that they were unaware of the source of Mr Zureikat's donations, the Commission has concluded that the charity trustees should have made further enquiries when accepting such large single and cumulative donations to satisfy themselves as to their origin and legitimacy. The Commission's conclusion is that the charity trustees did not properly discharge their duty of care as trustees to the Appeal in respect of these donations ... The Commission is also concerned, having considered the totality of the evidence before it, that Mr Galloway may also have known of the connection between the Appeal and the Programme. Galloway, in response, stated: "I've always disputed the Commission's retrospective view that a campaign to win a change in national and international policy – a political campaign – was, in fact, a charity".
== Awards and honours == 1998 Founders Award for Excellence from the Canadian College of Medical Geneticists. 1996 Honoured by Human Genome Organization at a special presentation in Heidelberg. 1996 Fellow of the American Association for the Advancement of Science. Fellow of the Canadian College of Medical Geneticists.
On 1 October, the Israeli military began an invasion of southern Lebanon, also known as the Third Lebanon War by some Israeli sources, and announced that Israel had been carrying out small covert raids into Lebanon for months. The IDF announced that it had launched "limited, localized and targeted raids" against targets with strategic importance to Hezbollah. An Israeli strike on a house in Al-Dawoudiya killed at least 10 people and injured five others. Hours after the initial Israeli raids began, Iran launched ballistic missiles against Israel, citing "terrorist acts of the Zionist regime" such as the assassination of Hassan Nasrallah as justification for the attack. On 3 October, six days after Nasrallah's assassination, his successor, Hashem Safieddine, was also assassinated during an Israeli airstrike in Beirut. Israel kept the extent of its campaign vague. On 29 October, IDF officers said that while some Lebanese villages still pose a threat to Israel, most military goals in Lebanon border area were fulfilled and conditions were created to cement Israel's achievements in ceasefire negotiations. On 26 November, hours after IDF troops reached the Litani River, Prime Minister of Israel Benjamin Netanyahu announced the transfer of a sixty-day ceasefire deal to the Security Cabinet of Israel. Support for the deal in the Israeli government was "unanimous". The deal involved Hezbollah operatives withdrawing to the north of the Litani River, and Israel withdrawing from Lebanon at the end of the sixty days.
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.